US Patent Issued to Jazz Pharmaceuticals Ireland on Feb. 17 for "Dosing and administration of recombinant L-asparaginase" (California Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,540, issued on Feb. 17, was assigned to Jazz Pharmaceuticals Ireland Ltd. (Dublin).

"Dosing and administration of recombinant L-asparaginase" was invented by Mi Rim Choi (Encino, Calif.), Tong Lin (Palo Alto, Calif.) and Jeffrey Silverman (Burlingame, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for treating a disease treatable by asparagine depletion in a human subject comprising dosing a human subject with L-asparaginase."

The patent was filed on March 30, 2022, under Application No. 17/709,166.

*For further information, including images, charts and tables, please visit: http://pat...